U.S Physical Therapy Price to Free Cash Flow Ratio 2010-2024 | USPH
Historical price to free cash flow ratio values for U.S Physical Therapy (USPH) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| U.S Physical Therapy Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-11-06 |
97.10 |
|
21.27 |
| 2024-06-30 |
91.94 |
$4.57 |
20.14 |
| 2024-03-31 |
111.81 |
$4.58 |
24.40 |
| 2023-12-31 |
91.88 |
$5.12 |
17.94 |
| 2023-09-30 |
90.05 |
$4.47 |
20.15 |
| 2023-06-30 |
118.66 |
$4.61 |
25.77 |
| 2023-03-31 |
95.34 |
$3.88 |
24.57 |
| 2022-12-31 |
78.55 |
$3.87 |
20.28 |
| 2022-09-30 |
73.34 |
$3.68 |
19.95 |
| 2022-06-30 |
104.84 |
$4.55 |
23.03 |
| 2022-03-31 |
95.11 |
$4.74 |
20.04 |
| 2021-12-31 |
90.98 |
$5.29 |
17.21 |
| 2021-09-30 |
104.91 |
$6.04 |
17.37 |
| 2021-06-30 |
109.53 |
$6.29 |
17.41 |
| 2021-03-31 |
98.11 |
$4.35 |
22.57 |
| 2020-12-31 |
112.99 |
$4.13 |
27.33 |
| 2020-09-30 |
81.64 |
$3.51 |
23.23 |
| 2020-06-30 |
76.13 |
$2.53 |
30.10 |
| 2019-12-31 |
107.03 |
$4.10 |
26.13 |
| 2019-09-30 |
121.88 |
$7.19 |
16.95 |
| 2019-06-30 |
114.17 |
$7.06 |
16.17 |
| 2019-03-31 |
97.61 |
$7.75 |
12.59 |
| 2018-12-31 |
94.87 |
$7.92 |
11.99 |
| 2020-03-31 |
64.84 |
$4.90 |
13.22 |
| 2018-09-30 |
109.72 |
$4.97 |
22.07 |
| 2018-06-30 |
88.63 |
$4.59 |
19.33 |
| 2018-03-31 |
74.87 |
$4.05 |
18.49 |
| 2017-12-31 |
66.31 |
$3.94 |
16.83 |
| 2017-09-30 |
56.27 |
$3.57 |
15.78 |
| 2017-06-30 |
55.12 |
$2.73 |
20.19 |
| 2017-03-31 |
59.22 |
$3.41 |
17.39 |
| 2016-12-31 |
63.67 |
$3.43 |
18.57 |
| 2016-09-30 |
56.71 |
$3.25 |
17.47 |
| 2016-06-30 |
54.31 |
$3.41 |
15.91 |
| 2016-03-31 |
44.72 |
$3.43 |
13.04 |
| 2015-12-31 |
48.11 |
$2.53 |
19.03 |
| 2015-09-30 |
40.11 |
$2.88 |
13.92 |
| 2015-06-30 |
48.79 |
$2.74 |
17.79 |
| 2015-03-31 |
42.19 |
$2.86 |
14.74 |
| 2014-12-31 |
37.15 |
$2.97 |
12.52 |
| 2014-09-30 |
31.24 |
$3.27 |
9.56 |
| 2014-06-30 |
30.08 |
$3.40 |
8.85 |
| 2014-03-31 |
30.30 |
$3.30 |
9.19 |
| 2013-12-31 |
30.79 |
$3.36 |
9.16 |
| 2013-09-30 |
27.05 |
$2.87 |
9.44 |
| 2013-06-30 |
23.98 |
$3.03 |
7.92 |
| 2013-03-31 |
23.20 |
$0.79 |
29.40 |
| 2012-12-31 |
23.70 |
$1.43 |
16.53 |
| 2012-09-30 |
23.34 |
$1.27 |
18.42 |
| 2012-06-30 |
21.41 |
$1.03 |
20.83 |
| 2011-12-31 |
16.43 |
$2.46 |
6.69 |
| 2011-09-30 |
15.40 |
$3.49 |
4.41 |
| 2011-06-30 |
20.48 |
$3.29 |
6.23 |
| 2011-03-31 |
18.44 |
$3.60 |
5.13 |
| 2010-12-31 |
16.24 |
$3.72 |
4.36 |
| 2012-03-31 |
19.33 |
$2.21 |
8.74 |
| 2010-09-30 |
13.70 |
$2.34 |
5.86 |
| 2010-06-30 |
13.83 |
$2.23 |
6.20 |
| 2010-03-31 |
14.25 |
$2.36 |
6.04 |
| 2009-12-31 |
13.87 |
$2.30 |
6.04 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$1.436B |
$0.605B |
|
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
|
